Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck

Anticancer Research

Volumn 26, Issue 1 B, 2006, Pages 559-563

  Baghi, Mehran ^a   Hambek, Markus ^a   May, Angelika ^a   Radeloff, Andreas ^a   Gstoettner, Wolfgang ^a   Knecht, Rainald ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Adjuvant chemotherapy; Docetaxel; Head and neck cancer

Indexed keywords

ANTIEMETIC AGENT; CIPROFLOXACIN; CISPLATIN; DEXAMETHASONE; DOCETAXEL; FLUOROURACIL; MAGNESIUM; POTASSIUM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; FEBRILE NEUTROPENIA; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; KIDNEY FAILURE; LYMPH NODE DISSECTION; MALE; MUCOSA INFLAMMATION; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; POLYPHARMACY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; TAXOIDS; TREATMENT OUTCOME;

EID: 32144457563     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bernier J and Cooper JS: Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence? Oncologist 10: 215-224, 2005.
2. Bernier J and Bentzen SM: Head and neck cancer management: which postoperative treatment best serves your patient? ASCO 306-312, 2003.
3. El Sayed S and Nelson N: Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a metaanalysis of prospective and randomized trials. J Clin Oncol 14: 838-887, 1996.
4. Murno A: An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71: 83-91, 1995.
5. Hughes RS and Frenkel EP: The role of chemotherapy in head and neck cancer. Am J Clin Oncol 20: 449-461, 1997.
6. Veterans Affairs Laryngeal Cancer Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324: 1685- 1689, 1991.
7. Broman GP, Hodson DI, Maknzie RJ et al: Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer. Head Neck 23: 579-589, 2001.
8. Colevas A, Busse P, Norris C et al: Induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL5) for squamous cell carcinoma of the head and neck. J Clin Oncol 16: 1331-1339, 1998.
9. Posner MR, Glisson B, Frenette G, Al-Sarraf M, Colevas AD, Norris CM, Seroskie JD, Shin DM, Olivares R and Garay CA: Multicenter phase I-II trial of docetaxel, cisplatin and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. J Clin Oncol 15: 1096-1104, 2001.
10. Janinis J, Papadakou M, Grassimos P et al: Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer. Am J Clin Oncol 24: 227-213, 2001.
11. Schrijvers D, Van Herpen C, Kerger J et al: Phase I/II study with docetaxel, cisplatin, 5-fluorouracil in patients with locally advanced inoperable squamous cell carcinoma of the head and neck. Proc Am Soc Clin Oncol 18: 1524, 1999.
12. Tsukuda M, Mikami Y, Tanigaki Y, Katori H, Horiuchi C, Ikeda Y, Taguchi T, Ono M, Yoshida T, Sakuma Y and Aikoh K: Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck. Int J Clin Oncol 9: 161-166, 2004.
13. Dreyfuss A, Clark J, Norris C et al: Taxotere for advanced inoperable squamous cell carcinoma of the head and neck (SCCHN). Proc Am Soc Clin Oncol 13: 287, 1994.
14. Licitra L, Grandi C, Guzzo M, Mariani L, Lo Vullo S, Valvo F et al: Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21: 327-333, 2003.
15. Milas R, Saito Y and Hunter N: Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma. Radiother Oncol 40: 163-170, 1996.
16. WAF1/CIP1. Br J Cancer 27: 82-85, 1996.
17. Tishler RB, Busse PM and Norris CM Jr: An initial experience using paclitaxel and radiation in the treatment of head and neck malignancies. Int J Radiat Oncol Biol Phys 43: 1001-1008, 1999.
18. Tishler RB, Norris CM Jr, Colevas AD et al: A phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck. Cancer 95: 1472-1481, 2002.
19. Janinis J, Papadakou M, Xidakis E et al: Combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer. Phase II feasibility study. Am J Clin Oncol 23: 128-131, 2000.
20. Wendt TG, Grabenbauer GG, Rodel GM et al: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer. J Clin Oncol 16: 1318-1324, 1998.